Biosimilar medications for oncology care improve access to effective treatment at a significant financial savings for health plans, health systems, and patients. First up, just what are biosimilars? Some people wonder if it’s just another term for generics. Biosimilars are not the same as generic versions of medications. Biosimilars are less expensive versions of already approved biologic […]